Arsanis, Inc. (ASNS)
ASNS Stock Chart More Charts
ASNS Price/Volume Stats
Arsanis, Inc. (ASNS) Company Bio
Arsanis, Inc., a clinical-stage biopharmaceutical company, focuses on applying monoclonal antibody (mAb) immunotherapies to address serious infectious diseases. Its lead product candidate is ASN100, a first-in-class mAb therapeutic in Phase II clinical development for the prevention of staphylococcus aureus pneumonia. The company’s preclinical pipeline comprises mAbs targeting multiple serious bacterial and viral pathogens, including respiratory syncytial virus. Arsanis, Inc. was founded in 2010 and is based in Waltham, Massachusetts.